Title: Research progress of decitabine in myelodysplastic syndromes
Abstract: It provides a new approach to treat myelodysplastic syndromes when decitabine comes out. In order to improve the understanding of the role of decitabine and to provide a reference for the clinical treatment of middle-risk and high-risk myelodysplastic syndromes, this article mianly summarized drug combination, prognostic molecular markers, and reviewed the mechanism of action, main medication regimen in recent 5 years for the treatment of middle-risk and high-risk myelodysplastic syndromes with decitabine.
Key words:
Deoxycholic acid/AA/TU; Myelodysplastic syndromes/DT; Review
Publication Year: 2017
Publication Date: 2017-08-20
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot